China Universal Asset Management Company’s Structure Therapeutics GPCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$666K	Buy	13,824 +2,936	+27%	+$201K	0.05%	239
2025 Q4	$757K	Buy	10,888 +444	+4%	+$18.1K	0.06%	210
2025 Q3	$292K	Sell	10,444 -1,523	-13%	-$30.3K	0.02%	297
2025 Q2	$248K	Buy	11,967 +16	+0.1%	+$352	0.02%	293
2025 Q1	$207K	Sell	11,951 -683	-5%	-$16.7K	0.02%	311
2024 Q4	$343K	Buy	12,634 +1,174	+10%	+$41.7K	0.03%	284
2024 Q3	$503K	Buy	11,460 +5,707	+99%	+$221K	0.06%	217
2024 Q2	$226K	Sell	5,753 -3,623	-39%	-$149K	0.03%	224
2024 Q1	$402K	Buy	9,376 +5,027	+116%	+$212K	0.05%	204
2023 Q4	$177K	Buy	4,349 +2,939	+208%	+$168K	0.03%	216
2023 Q3	$71.1K	Sell	1,410 -25,857	-95%	-$833K	0.02%	218
2023 Q2	$1.13M	Buy	+27,267	New	+$764K	0.35%	73